PPCH has the money to "today announced the Company received $1.2 million from an institutional investor in order to fast track its preclinical activities, including GMP (Good Manufacturing Practice) manufacturing and preparation for future patient trials". WOW!! There is just too much potential with this treatment to not ramp up activity to prepare of Phase I human trials....I do believe that PPCH is going to attract BP interest in the near future. When that news hits, I think we could see pps well above .10. Looking like a very exciting year! Phase I is around the corner!